Naloxone Hydrochloride
NDC 51316-210, Naloxone Hydrochloride, spray, from CVS Pharmacy, Inc.
- Product NDC
- 51316-210
- Status
- Listed
- Labeler
- CVS Pharmacy, Inc
- Dosage form
- SPRAY
- Route
- NASAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA217992
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51316-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NALOXONE HYDROCHLORIDE4 mg/.1mL
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51316-210-02 | 51316021002 | 2 VIAL in 1 CARTON (51316-210-02) / .1 mL in 1 VIAL (51316-210-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 51316-210 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51316-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51316-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.